Literature DB >> 8926368

What we have learned about bumetanide and the concept of multispecific bile acid/drug transporters from the liver.

E Petzinger1, M Blumrich, B Brühl, U Eckhardt, W Föllmann, W Honscha, J A Horz, N Müller, L Nickau, M Ottallah-Kolac, H D Platte, A Schenk, K Schuh, K Schulz, S Schulz.   

Abstract

Bumetanide is a weak organic acid which is transported into hepatocytes by a transport system that is related neither to the cloned sodium-dependent taurocholate cotransporting polypeptide Ntcp nor to the cloned organic anion transporting polypeptide oatp. Bumetanide is known to be transported in the kidney by a multispecific organic anion transporter which is the pAH-transporter from the proximal tubule cell. In the liver, bumetanide uptake competes with bile acid uptake, indicating a functionally related multispecific transporter for bile acids and drugs in hepatocytes. This multispecific bile acid transporter MBAT has not been cloned yet. When basolateral membranes were photoaffinity labeled with [3H]bumetanide, several bumetanide binding proteins were separated and identified after protein sequencing from two-dimensional electrophoresis gels.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8926368

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  2 in total

1.  Structure-activity relationships of bumetanide derivatives: correlation between diuretic activity in dogs and inhibition of the human NKCC2A transporter.

Authors:  Kasper Lykke; Kathrin Töllner; Kerstin Römermann; Peter W Feit; Thomas Erker; Nanna MacAulay; Wolfgang Löscher
Journal:  Br J Pharmacol       Date:  2015-08-04       Impact factor: 8.739

Review 2.  Hepatic glutathione and glutathione S-conjugate transport mechanisms.

Authors:  T K Lee; L Li; N Ballatori
Journal:  Yale J Biol Med       Date:  1997 Jul-Aug
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.